Intermittent Catheters Market Size & Growth Forecast 2027–2036, By Segments (Product Type, Category, End Use, Material, Application), Regional Demand Trends (North America, Asia Pacific, Europe), Key Country Insights (U.S., Japan, South Korea, Germany, France, Italy), and Competitive Landscape
Market Size and Growoth Outlook
Intermittent Catheters Market size stood at USD 2.78 Billion in 2026 and is predicted to grow at 4.43% CAGR from 2027 to 2036, exceeding USD 4.29 Billion by 2036. The industry revenue for 2027 is estimated at USD 2.88 Billion.
Get more details on this report
Request Free Sample ReportIntermittent Catheters Market Intelligence Snapshot
Regional Market Dynamics
- North America benefits from advanced healthcare infrastructure, established reimbursement frameworks, broad product access, and strong demand for clinically oriented catheterization solutions.
- Improving healthcare infrastructure, greater access to urological care, rising awareness, healthcare spending, and expanding specialist services are supporting regional adoption.
Segment Momentum
- Coated intermittent catheters led with a 62.54% share in 2026, driven by improved comfort, reduced friction, and growing preference for patient-focused catheterization solutions.
- Home care is the fastest-growing end-use segment as user-friendly designs and self-management trends support greater adoption outside healthcare facilities.
Market Expansion Drivers
- Growing prevalence of urinary disorders increasing demand for intermittent catheterization
- Favorable reimbursement policies improving patient access to catheter products
- Increasing preference for home-based self-catheterization supporting product adoption
Leading Market Participants
- Key players in the intermittent catheters market include Coloplast A/S (Denmark), B. Braun Melsungen AG (Germany), Becton, Dickinson and Company (USA), ConvaTec Group plc (UK), Hollister Incorporated (USA), Teleflex Incorporated (USA), Wellspect Healthcare (Sweden), Cook Medical (USA)
Global Market Forecast Snapshot
Market Outlook
- 2026 Market Size: USD 2.78 Billion
- 2027 Estimated Market Size: USD 2.88 Billion
- Projected Market Size: USD 4.29 Billion by 2036
- Growth Forecast: 4.43% CAGR (2027-2036)
Regional and Segment Outlook
- Leading Regional Market: North America
- High-Growth Regional Hub: Asia Pacific
- Core Revenue Segment: Coated Intermittent Catheter (Product Type) | Male Length (Category) | Hospitals and Specialty Clinics (End Use) | PVC (Material) | Urinary Incontinence (Application)
- Emerging Opportunity Segment: Coated Intermittent Catheter (Product Type) | Female Length (Category) | Home Care Settings (End Use) | Silicone (Material) | Spinal Injuries (Application)
Market Growth Drivers and Industry Trends
Growing prevalence of urinary disorders increasing demand for intermittent catheterization
The rising incidence of urinary retention, neurogenic bladder dysfunction, spinal cord injuries, and other urological conditions is creating sustained demand for intermittent catheterization, which will drive the intermittent catheters market growth. As healthcare providers increasingly recommend intermittent catheterization as an effective bladder management approach, the need for reliable, patient-friendly catheter products continues to expand across both hospital and community care settings. Growing awareness of early diagnosis and improved clinical management of chronic urinary disorders further supports wider utilization of intermittent catheters among diverse patient groups. Healthcare professionals also emphasize intermittent catheterization for reducing complications associated with prolonged indwelling catheter use, reinforcing routine product adoption in long-term care.
Favorable reimbursement policies improving patient access to catheter products
Supportive reimbursement frameworks are improving affordability and encouraging broader utilization of catheter products, helping propel the intermittent catheters market growth across multiple healthcare systems. Coverage for prescribed intermittent catheters reduces financial barriers for patients requiring long-term bladder management, enabling consistent access to clinically recommended products. Such reimbursement support also encourages healthcare professionals to prescribe advanced catheter designs that improve comfort, hygiene, and ease of use. Expanded insurance coverage across public and private healthcare programs contributes to greater treatment adherence while facilitating the availability of specialized catheter options through established distribution networks.
Increasing preference for home-based self-catheterization supporting product adoption
As healthcare delivery increasingly shifts toward patient-centered care, the intermittent catheters market is benefiting from the growing preference for home-based self-catheterization. Patients value the independence, flexibility, and privacy associated with managing bladder care outside institutional settings, encouraging demand for catheters designed for convenient self-use. Manufacturers are introducing compact, discreet, and easy-to-handle products that simplify catheterization while supporting hygiene and portability during daily activities. Educational initiatives from healthcare providers and improved patient training also strengthen confidence in self-catheterization techniques, contributing to broader acceptance across individuals managing chronic urinary conditions.
| Growth Driver | Impact on CAGR | Regulatory Influence | Geographic Relevance | Adoption Rate | Impact Timeline |
|---|---|---|---|---|---|
| Growing prevalence of urinary disorders increasing demand for intermittent catheterization | 2% | Moderate | North America, Europe, Asia Pacific | High | Near Term |
| Favorable reimbursement policies improving patient access to catheter products | 1.8% | High | North America, Europe | High | Near Term |
| Increasing preference for home-based self-catheterization supporting product adoption | 1.5% | Moderate | Europe, North America, Asia Pacific | Medium | Mid Term |
Unlock insights tailored to your business with our bespoke market research solutions.
Click to get your customized report now.
Regional Demand Dynamics
North America (Largest Region)
North America dominated the intermittent catheters market in 2026, supported by advanced healthcare infrastructure, high awareness of catheter-based urinary management, and broad access to specialized medical products. The region benefits from established reimbursement frameworks and strong adoption of clinically oriented products designed to improve patient comfort, hygiene, and ease of use. Increasing demand associated with urinary disorders, neurological conditions, and populations requiring long-term bladder management is further supporting utilization, while product innovation focused on safer and more convenient catheterization is strengthening adoption.
Asia Pacific (Fastest-Growing Region)
Asia Pacific is poised to achieve the fastest growth, driven by improving healthcare infrastructure, expanding access to urological care, and rising awareness of intermittent catheterization as a method of bladder management. Healthcare systems across emerging economies are placing greater emphasis on improving treatment access and reducing complications associated with urinary conditions, creating opportunities for catheter adoption. In addition, increasing healthcare expenditure, expanding specialist services, and broader availability of advanced medical devices are expected to support greater use of intermittent catheters across the region.
| Parameter | North America | Asia Pacific | Europe | Latin America | MEA |
|---|---|---|---|---|---|
| Innovation Hub i Scale Nascent Developing Advanced | |||||
| Cost-Sensitive Region i Scale Low Medium High | |||||
| Regulatory Environment i Scale Restrictive Neutral Supportive | |||||
| Demand Drivers i Scale Weak Moderate Strong | |||||
| Development Stage i Scale Emerging Developing Developed | |||||
| Adoption Rate i Scale Low Medium High | |||||
| New Entrants / Startups i Scale Sparse Moderate Dense | |||||
| Macro Indicators i Scale Weak Stable Strong |
Key Country Insights
United States 🇺🇸
Homecare Innovation FocusThe U.S. intermittent catheters market emphasizes patient-friendly designs, infection prevention, and reimbursement-supported access. Healthcare providers in the U.S. continue to prioritize products that improve comfort, support self-catheterization, and integrate with expanding home-based care pathways.
Germany 🇩🇪
Clinical Quality StandardsGermany prioritizes clinically validated intermittent catheters that align with hospital procurement requirements and outpatient continence management. Manufacturers serving Germany increasingly focus on product reliability, sustainability, and compliance with stringent healthcare quality expectations.
Japan 🇯🇵
Aging Care SolutionsJapan's intermittent catheters market is shaped by growing demand for solutions supporting elderly patients and long-term urinary care. Healthcare providers in Japan value compact, easy-to-use catheter systems that enhance patient independence while reducing complications during routine use.
South Korea 🇰🇷
Advanced Urology AdoptionSouth Korea supports adoption of technologically refined intermittent catheters through modern healthcare infrastructure and specialized urology services. Manufacturers in South Korea increasingly introduce ergonomic and hydrophilic catheter designs to improve patient convenience and clinical outcomes.
France 🇫🇷
Outpatient Care SupportFrance emphasizes intermittent catheters suited for outpatient treatment and long-term continence management. Suppliers in France focus on improving user comfort, reducing infection risks, and supporting healthcare professionals with products aligned to established clinical care pathways.
Italy 🇮🇹
Hospital Procurement AlignmentItaly's intermittent catheters market is influenced by public hospital purchasing practices and expanding homecare utilization. Manufacturers serving Italy focus on dependable product performance, clinician familiarity, and cost-effective solutions that support routine urinary management across care settings.
Segment Leadership and Growth Trends
Intermittent Catheters Market Share (%), by Product Type, 2026
Go beyond the chart, access full insights & data tables
Request Free Sample ReportProduct Type Segment Analysis: Coated Intermittent Catheter (Largest & Fastest-Growing Segment)
The coated intermittent catheter segment dominated the intermittent catheters market with a 62.54% share in 2026 and also emerged as the fastest-growing segment. Its strong market position is driven by the increasing preference for catheters designed to enhance patient comfort and reduce friction during insertion and removal. Coated products help improve the overall catheterization experience, making them particularly suitable for individuals requiring long-term or frequent use. Growing awareness of infection prevention, advancements in catheter coating technologies, and the rising emphasis on patient-centric urological care are further supporting adoption. As healthcare providers and patients increasingly prioritize safety, convenience, and ease of use, demand for coated intermittent catheters continues to strengthen across both clinical and home-care settings.
Category Segment Analysis: Male Length (Largest Segment) vs Female Length (Fastest-Growing Segment)
Holding a 48.97% share in 2026, the male length catheter segment represented the largest category within the intermittent catheters market. The segment’s leadership is largely supported by the extensive availability of products tailored to male anatomical requirements and the significant utilization of intermittent catheterization for managing urinary retention and related urological conditions. Continuous product improvements focused on comfort, usability, and infection control have also reinforced the segment’s established position.
The female length catheter segment is witnessing the fastest growth due to increasing awareness of urinary health management among women and improved access to specialized urological care. Manufacturers are introducing products specifically designed for female users, emphasizing discretion, portability, and ease of handling. The growing acceptance of self-catheterization and expanding home-based care practices are further contributing to the rapid adoption of female length intermittent catheters.
End Use Segment Analysis: Hospitals and Specialty Clinics (Largest Segment) vs Home Care Settings (Fastest-Growing Segment)
The hospitals and specialty clinics segment led the intermittent catheters market with a 47.06% share in 2026. These facilities remain the primary point of diagnosis, treatment, and ongoing management for patients requiring catheterization. Access to trained healthcare professionals, specialized equipment, and comprehensive patient education programs supports the continued dominance of this segment. Hospitals and specialty clinics also play a crucial role in initiating catheterization therapies and monitoring patients with complex urological conditions.
Home care settings are emerging as the fastest-growing end-use segment as healthcare systems increasingly encourage patient self-management and outpatient care. Advancements in user-friendly catheter designs, combined with growing patient confidence in performing catheterization independently, are driving adoption in home environments. The shift toward personalized care, greater convenience, and reduced dependence on hospital visits is expected to continue supporting growth in this segment.
| Segment | Sub-Segment | Largest Segment | Fastest Growing |
|---|---|---|---|
| Product Type | Coated Intermittent Catheter, Uncoated Intermittent Catheter | Coated Intermittent Catheter | Coated Intermittent Catheter |
| Category | Male Length, Female Length, Pediatric Length | Male Length | Female Length |
| End Use | Hospitals and Specialty Clinics, Ambulatory Surgical Centers, Home Care Settings, Others | Hospitals and Specialty Clinics | Home Care Settings |
| Material | PVC, Silicone, Latex, Others | PVC | Silicone |
| Application | Urinary Incontinence, General Surgery, Spinal Injuries, Others | Urinary Incontinence | Spinal Injuries |
Competitive Landscape and Market Positioning
Key companies in the intermittent catheters market:
- Coloplast A/S (Denmark)
- B. Braun Melsungen AG (Germany)
- Becton Dickinson and Company (USA)
- ConvaTec Group plc (UK)
- Hollister Incorporated (USA)
- Teleflex Incorporated (USA)
- Wellspect Healthcare (Sweden)
- Cook Medical (USA)
The intermittent catheters market is evolving through a stronger emphasis on patient-centric design, clinical performance, and ease of use, driving suppliers to differentiate beyond traditional catheter functionality. Manufacturers are focusing on innovations that improve comfort, reduce complications, and support better adherence among users managing long-term care needs. Competitive positioning is increasingly influenced by product usability, material advancements, and the ability to address diverse patient requirements across healthcare settings. Companies with strong clinical understanding and adaptable product portfolios are gaining relevance as healthcare providers prioritize outcomes alongside cost considerations.
| Company | Market Share | Company Revenue | Revenue CAGR (%) | Product Portfolio | Geographic Presence | Innovation / R&D Focus | Strategic Developments |
|---|---|---|---|---|---|---|---|
| Coloplast A/S (Denmark) | |||||||
| B. Braun Melsungen AG (Germany) | |||||||
| Becton Dickinson and Company (USA) | |||||||
| ConvaTec Group plc (UK) | |||||||
| Hollister Incorporated (USA) | |||||||
| Teleflex Incorporated (USA) | |||||||
| Wellspect Healthcare (Sweden) | |||||||
| Cook Medical (USA) |
Industry Development/News
| Company Name | Date | Key Development |
|---|---|---|
| ConvaTec | Jun-25 | ConvaTec introduced the GentleCath Air, a compact intermittent catheter designed for women. The device integrates FeelClean Technology that activates upon removal from its case to deliver a smooth, lubricated surface, facilitating easier insertion and removal operations for users. |
| Coloplast | May-24 | Coloplast expanded its Luja portfolio with the launch of a next-generation intermittent catheter for women featuring over 50 micro-holes for complete bladder emptying and reduced urinary tract infection risks. Clinical studies indicated 87 percent of catheterizations had zero flow stops and 83 percent showed less than 10 mL of residual urine. The sustainable design utilizes 28 percent less plastic and achieves a 22 percent lower carbon footprint. |
| HR Pharmaceuticals, Inc. | Oct-23 | HR Pharmaceuticals, Inc. expanded its TruCath portfolio by introducing the TruCath Hydrophilic Intermittent Catheter and the TruCath Closed System Intermittent Catheter to enhance patient comfort and safety. The hydrophilic variant incorporates a lubricious coating that activates upon water exposure to minimize friction during insertion and removal procedures. |
Customize Your Report
Explore examples of how this report can be tailored to different research needs, including custom segments, additional topics or chapters, and related reports. Click a section of the wheel or its numbered marker to explore the available options.
Intermittent Catheters Market — Custom Segments
| Segment | Sub-Segment |
|---|---|
| Lubrication Type | Pre-Lubricated, Hydrophilic-Coated, Unlubricated |
| User Skill Level | Self-Catheterization, Assisted Catheterization, Clinician-Performed Catheterization |
| Reimbursement Type | Publicly Reimbursed, Privately Reimbursed, Self-Pay |
Intermittent Catheters Market — Custom
| Custom Chapter | Custom Details |
|---|---|
| Patient Adherence & Catheter Preference Assessment |
|
| Home Healthcare Adoption Opportunity Analysis |
|
| Reimbursement Access & Coverage Benchmarking |
|
Need a different cut of the data?
Request Custom ResearchWhat is the current revenue of the intermittent catheters market?
How is the intermittent catheters industry size expected to evolve during the forecast period?
How is the shift toward home-based care influencing intermittent catheter adoption?
Why are reimbursement policies strategically important in the intermittent catheters market?
Why are coated intermittent catheters preferred in the market?
How is the home care segment changing demand for intermittent catheters?
How does North America maintain its lead in intermittent catheters?
Why is Asia Pacific expected to grow fastest in intermittent catheters?
Which companies are driving growth in the intermittent catheters landscape?
Our Clients
"The reports offered a comprehensive view of the Food and Beverage landscape, covering market trends, consumer behavior, and competitive dynamics."
"Our experience in acquiring market research reports has been outstanding — the depth of analysis and actionable insights have proven invaluable."
"Fundamental Business Insights demonstrated a keen understanding of our business needs, delivering reports tailored to our specific objectives."
Our Research Team & Methodology
Every Fundamental Business Insights report is built by a dedicated vertical research team, validated through a structured primary-and-secondary methodology, and reviewed for accuracy before it reaches you.
Research Team Overview
Prepared by the Healthcare & Medical Devices Research Team
Delivery
Published
Demand
Available
Support
Trust & Compliance
Research Domains
10 coverage areasResearch Intelligence
| Source | Why It Matters | Reference |
|---|---|---|
| World Health Organization (WHO) | Global health statistics, disease burden, healthcare policies | www.who.int |
| U.S. Food & Drug Administration (FDA) | Medical devices, pharmaceuticals, diagnostics, approvals | www.fda.gov |
| European Medicines Agency (EMA) | Pharmaceutical approvals and regulatory guidance in Europe | www.ema.europa.eu |
| Centers for Disease Control and Prevention (CDC) | Disease surveillance, public health, epidemiology | www.cdc.gov |
| National Institutes of Health (NIH) | Biomedical research, clinical studies, funding | www.nih.gov |
| National Center for Biotechnology Information (NCBI) | Biomedical databases, PubMed, genomics | www.ncbi.nlm.nih.gov |
| PubMed | Peer-reviewed biomedical literature | pubmed.ncbi.nlm.nih.gov |
| ClinicalTrials.gov | Global clinical trial registry | clinicaltrials.gov |
| International Organization for Standardization (ISO) | Medical device quality and healthcare standards | www.iso.org |
| ASTM International | Medical device testing and material standards | www.astm.org |
| Advanced Medical Technology Association (AdvaMed) | Medical devices and diagnostics industry | www.advamed.org |
| Medical Device Innovation Consortium (MDIC) | Medical device innovation and regulatory science | mdic.org |
| Biotechnology Innovation Organization (BIO) | Biotechnology industry developments | www.bio.org |
| International Federation of Pharmaceutical Manufacturers & Associations (IFPMA) | Global pharmaceutical industry | www.ifpma.org |
| U.S. Pharmacopeia (USP) | Drug quality standards and reference materials | www.usp.org |
| European Directorate for the Quality of Medicines & HealthCare (EDQM) | European pharmaceutical quality standards | www.edqm.eu |
| World Organisation for Animal Health (WOAH) | Veterinary healthcare and animal diseases | www.woah.org |
| American Hospital Association (AHA) | Hospital operations and healthcare delivery | www.aha.org |
| OECD Health | International healthcare expenditure and system statistics | www.oecd.org/health |
| World Bank Data | Healthcare expenditure and demographic indicators | data.worldbank.org |
Research Workflow & Quality Assurance
Data Collection
Verified information gathered through primary and secondary research.
Data Triangulation
Cross-validation using multiple independent data sources.
Forecast Modelling
Market estimates developed using historical trends and analytical models.
Analyst Validation
Findings reviewed by domain experts for accuracy and consistency.
Editorial & Quality Review
Final editorial, quality, and compliance checks before publication.
Final Publication
Released after successful completion of the internal review process.
Report Coverage
📊 Market Assessment
- Market Size & Forecast
- Market Segmentation
- Regional Analysis
- Growth Drivers & Challenges
- Market Dynamics
🏢 Competitive Intelligence
- Competitive Landscape
- Company Profiles
- Competitive Benchmarking
- Mergers & Acquisitions
- Market Share Analysis or Key Company Strategies
🔍 Strategic Analysis
- Value Chain Analysis
- Porter's Five Forces
- PESTLE Analysis
- Pricing Trends
- Supply-Demand Analysis
🚀 Future Outlook
- Technology Landscape
- Regulatory Landscape
- Investment & Funding Landscape
- Emerging Opportunities
- Future Market Outlook
Have a question about this report or need a custom scope?
Request Customization